Evidence map›Paper›PMID 35515456›Full record

ArticleRSC advances2020

Nanoformulation-by-design: an experimental and molecular dynamics study for polymer coated drug nanoparticles.

Ioanna Danai Styliari, Vincenzo Taresco, Andrew Theophilus, Cameron Alexander, Martin Garnett, Charles Laughton

Abstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Investigation of Novel Antiproliferative Drugs Interaction with mPEGJournal of chemical information and modeling · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ioanna Danai StyliariSchool of Pharmacy, University of Nottingham Nottingham NG7 2RD UK.ORCID https://orcid.org/0000-0002-7476-2994
Vincenzo TarescoSchool of Pharmacy, University of Nottingham Nottingham NG7 2RD UK.ORCID https://orcid.org/0000-0003-4476-8233
Andrew TheophilusGlaxoSmithKline R&D Gunnels Wood Rd Stevenage SG1 2NY UK.
Cameron AlexanderSchool of Pharmacy, University of Nottingham Nottingham NG7 2RD UK.ORCID https://orcid.org/0000-0001-8337-1875
Martin GarnettSchool of Pharmacy, University of Nottingham Nottingham NG7 2RD UK.ORCID https://orcid.org/0000-0002-4365-4499
Charles LaughtonSchool of Pharmacy, University of Nottingham Nottingham NG7 2RD UK.ORCID https://orcid.org/0000-0003-4090-3960

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The formulation of drug compounds into nanoparticles has many potential advantages in enhancing bioavailability and improving therapeutic efficacy. However, few drug molecules will assemble into stable, well-defined nanoparticulate structures. Amphiphilic polymer coatings are able to stabilise nanoparticles, imparting defined surface properties for many possible drug delivery applications. In the present article we explore, both experimentally and

Identifiers

PMID35515456
PMCPMC9054057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.